A detailed history of Clearwater Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Clearwater Capital Advisors, LLC holds 1,829 shares of AMGN stock, worth $537,726. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,829
Previous 1,840 0.6%
Holding current value
$537,726
Previous $574,000 2.61%
% of portfolio
0.06%
Previous 0.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $3,403 - $3,711
-11 Reduced 0.6%
1,829 $589,000
Q2 2024

Aug 06, 2024

SELL
$262.75 - $319.31 $4,992 - $6,066
-19 Reduced 1.02%
1,840 $574,000
Q1 2024

May 09, 2024

SELL
$268.87 - $324.56 $3,495 - $4,219
-13 Reduced 0.69%
1,859 $528,000
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $17,643 - $19,903
69 Added 3.83%
1,872 $539,000
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $6,773 - $8,256
-30 Reduced 1.64%
1,803 $435,000
Q4 2022

Jan 27, 2023

SELL
$229.03 - $291.01 $3,206 - $4,074
-14 Reduced 0.76%
1,833 $0
Q3 2022

Nov 01, 2022

SELL
$224.46 - $253.15 $8,080 - $9,113
-36 Reduced 1.91%
1,847 $416,000
Q2 2022

Jul 21, 2022

BUY
$230.71 - $256.74 $11,535 - $12,837
50 Added 2.73%
1,883 $458,000
Q2 2021

Aug 04, 2021

SELL
$233.58 - $259.14 $233 - $259
-1 Reduced 0.05%
1,833 $447,000
Q4 2020

Jan 21, 2021

BUY
$216.38 - $257.67 $216 - $257
1 Added 0.05%
1,834 $422,000
Q2 2020

Jul 30, 2020

SELL
$197.81 - $242.74 $4,945 - $6,068
-25 Reduced 1.35%
1,833 $432,000
Q1 2020

Apr 15, 2020

SELL
$182.24 - $241.7 $9,294 - $12,326
-51 Reduced 2.67%
1,858 $377,000
Q4 2019

Jan 27, 2020

SELL
$189.21 - $243.2 $3,594 - $4,620
-19 Reduced 0.99%
1,909 $460,000
Q4 2018

Jan 22, 2019

SELL
$178.4 - $208.25 $12,488 - $14,577
-70 Reduced 3.5%
1,928 $375,000
Q3 2018

Oct 17, 2018

SELL
$185.29 - $208.89 $53,548 - $60,369
-289 Reduced 12.64%
1,998 $414,000
Q2 2017

Aug 11, 2017

BUY
N/A
2,287
2,287 $394,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Clearwater Capital Advisors, LLC Portfolio

Follow Clearwater Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearwater Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearwater Capital Advisors, LLC with notifications on news.